modern spreadsheet innovations

Agentic AI delivers real results when data plumbing comes first.

Merck and Mastercard are witnessing significant advancements in agentic AI by prioritizing foundational infrastructure.

4 min readVentureBeat
Agentic AI delivers real results when data plumbing comes first.

The recent advancements in agentic AI applications at Merck and Mastercard highlight a crucial lesson for organizations venturing into the AI landscape: robust infrastructure is foundational to innovation. Merck's experience, as articulated by VP of Digital Platforms Sean Finnerty, reveals that their significant improvements in drug discovery and marketing material compliance stem not just from the AI itself, but from a strategically constructed digital "plumbing" that supports these innovations. This mirrors the broader industry shift towards recognizing the importance of a strong foundational infrastructure, a topic that has been brought to light in various conversations, such as those surrounding the implications of AI in sectors like finance and healthcare. For instance, Google just broke SEO. Here’s what replaces it. underscores the need for reliable frameworks as we transition into an AI-centric world.

The significance of this plumbing-first approach cannot be overstated. It acts as a safeguard against the pitfalls of disjointed solutions that can lead to what Finnerty terms “debt” — an accumulation of outdated systems that stifle further innovation. By investing in a cohesive infrastructure, companies can better facilitate the integration and operation of various AI agents, enabling them to operate more efficiently and effectively across multiple workflows. As AI begins to permeate enterprise operations, the lessons learned from Merck’s successes will undoubtedly inform other organizations looking to harness AI for transformative results.

Moreover, the insights shared by Finnerty about the practical applications of AI in drug discovery and marketing speak volumes about the potential of these technologies to redefine timelines and enhance productivity. For example, the ability to generate marketing drafts that are "99% right" in terms of compliance is a game changer for an industry notorious for its regulatory complexities. Not only does this accelerate delivery times significantly, but it also frees human resources to focus on strategic oversight rather than getting bogged down in the minutiae of compliance checks. This is reminiscent of the challenges faced in sectors like financial services, where organizations are grappling with the nuances of trust and efficiency, as detailed in Use cases for agentic AI in financial services.

Looking ahead, the journey toward fully leveraging AI will undoubtedly come with challenges. The “wackiness” Finnerty encountered, where AI generated nonsensical scenarios, serves as a reminder that while AI has advanced, it is not infallible. The need for guardrails and supervision in AI operations emphasizes the importance of a thoughtful approach to AI deployment, one that combines human oversight with automated processes. This balance will be vital as organizations look to scale their AI initiatives while maintaining control over the outcomes.

As the industry progresses, one question remains: how will organizations ensure the integrity of their AI systems while navigating the complexities of implementation? The path to successful AI integration is multifaceted, involving not just the technological capabilities but also a commitment to continual learning and adaptation. The experiences of Merck and Mastercard offer valuable lessons for others in the field, illustrating the need for a robust infrastructure that supports innovative solutions while instilling confidence in their use. The future of AI in enterprise settings will depend on how effectively organizations can learn from these early adopters and build frameworks that empower their data-driven aspirations.

From VentureBeat

Merck is using AI agents to cut drug discovery cycles by a third and ship compliant marketing materials up to 80% faster — but VP of Digital Platforms Sean Finnerty says the only reason it's working is because they built the infrastructure first.

And the pharmaceutical manufacturer is seeing promising early results: AI is generating marketing drafts that are “99% right” when it comes to compliance, shrinking review cycles from months to days and accelerating delivery by 70% to 80%. In the company’s medical research, meanwhile, one AI-assisted discovery cycle was reduced by 33%.

Read the original at VentureBeat